Meptazinol cross-tolerance studies between morphine or oxotremorine

Area of Science:

• Pharmacology
• Neuroscience
• Pain Research

Background:

• Opioid analgesics like meptazinol are crucial for pain management.
• Understanding drug tolerance is essential for optimizing therapeutic efficacy.
• Meptazinol exhibits both partial agonist and cholinergic properties.

Purpose of the Study:

• To examine the development of auto-tolerance to meptazinol.
• To investigate cross-tolerance between meptazinol, morphine, and oxotremorine.
• To elucidate the mechanisms underlying meptazinol tolerance.

Main Methods:

• Mice were treated with meptazinol (10 mg and 30 mg/kg s.c.) twice daily for eight days.
• Nociceptive tests (heat and pressure) were used to assess antinociceptive effects.
• Cross-tolerance was evaluated by challenging meptazinol-treated mice with morphine and oxotremorine.

Main Results:

• Meptazinol treatment induced cross-tolerance to morphine at both tested doses.
• Morphine-tolerant mice showed no cross-tolerance to meptazinol, which retained antinociceptive effects.
• Chronic meptazinol administration led to cross-tolerance with oxotremorine.

Conclusions:

• A one-way tolerance exists between morphine and meptazinol.
• Higher doses of meptazinol induce full tolerance with oxotremorine, suggesting distinct but overlapping pathways.
• These findings contribute to understanding analgesic tolerance mechanisms.